Order Article Reprints

Saavedra C, Vallejo A, Longo F, Serrano JJ, Fernández M, Gion M, López-Miranda E, Martínez-Jáñez N, Guerra E, Chamorro J, et al. Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers. 2023; 15(7):2000. https://doi.org/10.3390/cancers15072000

Saavedra, Cristina, Alejandro Vallejo, Federico Longo, Juan José Serrano, María Fernández, María Gion, Elena López-Miranda, Noelia Martínez-Jáñez, Eva Guerra, Jesús Chamorro, and et al. 2023. "Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors" Cancers 15, no. 7: 2000. https://doi.org/10.3390/cancers15072000

Saavedra, C., Vallejo, A., Longo, F., Serrano, J. J., Fernández, M., Gion, M., López-Miranda, E., Martínez-Jáñez, N., Guerra, E., Chamorro, J., Rosero, D., Velasco, H., Martín, A., Carrato, A., Casado, J. L., & Cortés, A. (2023). Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers, 15(7), 2000. https://doi.org/10.3390/cancers15072000